{"transactions":[{"id":4639829,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-13","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":272848,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639828,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":284729,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639827,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-09","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option is fully vested and exercisable."}],"balance_after":296610,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639826,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-13","kind":"sale","planned":true,"acquired":false,"shares":11881,"price":25.5,"value":302965.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.10 to $25.80, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639825,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-13","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639824,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":2700,"price":26.07,"value":70389.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.83 to $26.31, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639823,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-12","kind":"sale","planned":true,"acquired":false,"shares":9181,"price":25.35,"value":232738.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $25.81, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":380502,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639822,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-12","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639821,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-09","kind":"sale","planned":true,"acquired":false,"shares":11881,"price":26.41,"value":313777.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.99 to $26.80, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4639820,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-13T23:05:56.000Z","date":"2026-10-09","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000039","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000039/form4.xml","form_type":"4"}},{"id":4638198,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":308491,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638197,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-07","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":320372,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638196,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option is fully vested and exercisable."}],"balance_after":332253,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638195,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":11881,"price":25.66,"value":304866.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.23 to $26.09, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638194,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638193,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-07","kind":"sale","planned":true,"acquired":false,"shares":11881,"price":26.4,"value":313658.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.95 to $26.88, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638192,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-07","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638191,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":499,"price":30.53,"value":15234.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.34 to $30.68, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638190,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":901,"price":29.71,"value":26768.71,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.19 to $30.18, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":378301,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638189,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":28.21,"value":31031.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.89 to $28.75, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":379202,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638188,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":9381,"price":27.36,"value":256664.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.89 to $27.87, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":380302,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638187,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-08T22:54:47.000Z","date":"2026-10-06","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000037/form4.xml","form_type":"4"}},{"id":4638186,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":24102,"kind":"person","name":"BOBULSKY SUSAN","position":1,"cik":"0001820885","reported_name":"BOBULSKY SUSAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer, MRD"}}],"security":"Common Stock","published_at":"2026-10-08T22:52:42.000Z","date":"2026-10-06","kind":"sale","planned":true,"acquired":false,"shares":6444,"price":30,"value":193320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":389350,"source":{"system":"sec-edgar","filing":"0001820885-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820885/000182088526000025/form4.xml","form_type":"4"}},{"id":4631450,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is fully vested and exercisable."}],"balance_after":344134,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631449,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is fully vested and exercisable."}],"balance_after":356015,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631448,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":11881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is fully vested and exercisable."}],"balance_after":367896,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":11881},"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631447,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":5182,"price":29.67,"value":153749.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.32 to $29.82, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631446,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":6699,"price":28.82,"value":193065.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.30 to $29.29, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":382984,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631445,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631444,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":11881,"price":28.13,"value":334212.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.62 to $28.37, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631443,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631442,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":5800,"price":28.56,"value":165648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.22 to $28.83, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":377802,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631441,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":6081,"price":27.57,"value":167653.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $28.11, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":383602,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631440,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":50874,"kind":"person","name":"RUBINSTEIN JULIE","position":1,"cik":"0001780664","reported_name":"RUBINSTEIN JULIE","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2026-10-06T00:15:44.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":11881,"price":12.14,"value":144235.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025."}],"balance_after":389683,"source":{"system":"sec-edgar","filing":"0001780664-26-000035","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780664/000178066426000035/form4.xml","form_type":"4"}},{"id":4631439,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":9377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":93765,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":9377},"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631438,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":9377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":56259,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":9377},"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631437,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":8038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":16075,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":8038},"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631436,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":18698,"price":28.61,"value":534949.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.33 to $29.00, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":220867,"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631435,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":8094,"price":27.52,"value":222746.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.22 to $28.22, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":239565,"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631434,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":9377,"price":8.12,"value":76141.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":247659,"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631433,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":9377,"price":3.99,"value":37414.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":238282,"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4631432,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-10-06T00:12:52.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":8038,"price":8.46,"value":68001.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":228905,"source":{"system":"sec-edgar","filing":"0001780660-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000024/form4.xml","form_type":"4"}},{"id":4622122,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":24102,"kind":"person","name":"BOBULSKY SUSAN","position":1,"cik":"0001820885","reported_name":"BOBULSKY SUSAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer, MRD"}}],"security":"Common Stock","published_at":"2026-09-17T22:50:34.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1195,"price":27,"value":32265.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":395794,"source":{"system":"sec-edgar","filing":"0001820885-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1820885/000182088526000023/form4.xml","form_type":"4"}},{"id":1368,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":1127,"kind":"person","name":"OWEN KATEY EINTERZ","position":1,"cik":"0001852578","reported_name":"OWEN KATEY EINTERZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-02T23:12:41.000Z","date":"2026-08-31","kind":"gift","planned":false,"acquired":false,"shares":12539,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price is not applicable to dispositions resulting from bona fide gifts."}],"balance_after":66100,"source":{"system":"sec-edgar","filing":"0001852578-26-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852578/000185257826000007/form4.xml","form_type":"4"}},{"id":673072,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":1127,"kind":"person","name":"OWEN KATEY EINTERZ","position":1,"cik":"0001852578","reported_name":"OWEN KATEY EINTERZ","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T17:50:00.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":9615,"price":26,"value":249990.0,"ownership":{"direct":true},"balance_after":78639,"source":{"system":"sec-edgar","filing":"0001852578-26-000005","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1852578/000185257826000005/form4.xml","form_type":"4"}},{"id":679853,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was fully vested and exercisable and would have expired on October 18, 2026."}],"balance_after":0,"derivative":{"exercise_price":6.32,"expiration_date":"2026-10-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":679852,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":15664,"price":24.41,"value":382358.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.40 to $24.44, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":46683,"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":679851,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":24.39,"value":365850.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.38 to $24.43, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":62347,"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":679850,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21219,"kind":"person","name":"HERSHBERG ROBERT","position":1,"cik":"0001274139","reported_name":"HERSHBERG ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T21:55:47.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":6.32,"value":94800.0,"ownership":{"direct":true},"balance_after":77347,"source":{"system":"sec-edgar","filing":"0001274139-26-000004","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000127413926000004/form4.xml","form_type":"4"}},{"id":681481,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":278676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested and exercisable and would have expired on February 7, 2028."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":278676},"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681480,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-17","kind":"exercise","planned":false,"acquired":false,"shares":321324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested and exercisable and would have expired on February 7, 2028."}],"balance_after":278676,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":321324},"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681479,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":204,"price":25.14,"value":5128.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions all at $25.14. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":2180518,"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681478,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":278472,"price":24.48,"value":6816994.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.12 to $25.12, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":2180722,"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681477,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":278676,"price":6.55,"value":1825327.8,"ownership":{"direct":true},"balance_after":2459194,"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681476,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":2525,"price":25.57,"value":64564.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.52 to $25.64, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":2180518,"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681475,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":318799,"price":25.08,"value":7995478.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.51 to $25.50, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":2183043,"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681474,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21662,"kind":"person","name":"ROBINS CHAD M","position":1,"cik":"0001780649","reported_name":"ROBINS CHAD M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-08-20T00:15:10.000Z","date":"2026-08-17","kind":"exercise","planned":false,"acquired":true,"shares":321324,"price":6.55,"value":2104672.2,"ownership":{"direct":true},"balance_after":2501842,"source":{"system":"sec-edgar","filing":"0001780649-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780649/000178064926000014/form4.xml","form_type":"4"}},{"id":681338,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21623,"kind":"person","name":"NEUPERT PETER M","position":1,"cik":"0001237566","reported_name":"NEUPERT PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-20T00:07:56.000Z","date":"2026-08-17","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The option was fully vested and exercisable and would have expired on October 18, 2026."}],"balance_after":0,"derivative":{"exercise_price":6.32,"exercise_date":"2026-10-18","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001237566-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000123756626000003/primary_doc.xml","form_type":"4"}},{"id":681337,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21623,"kind":"person","name":"NEUPERT PETER M","position":1,"cik":"0001237566","reported_name":"NEUPERT PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T00:07:56.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":69690,"price":25.16,"value":1753400.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.14 to $25.22, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":130625,"source":{"system":"sec-edgar","filing":"0001237566-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000123756626000003/primary_doc.xml","form_type":"4"}},{"id":681336,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21623,"kind":"person","name":"NEUPERT PETER M","position":1,"cik":"0001237566","reported_name":"NEUPERT PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T00:07:56.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":40000,"price":25.1,"value":1004000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.17, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":200315,"source":{"system":"sec-edgar","filing":"0001237566-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000123756626000003/primary_doc.xml","form_type":"4"}},{"id":681335,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21623,"kind":"person","name":"NEUPERT PETER M","position":1,"cik":"0001237566","reported_name":"NEUPERT PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T00:07:56.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":25.23,"value":378450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.21 to $25.27, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":240315,"source":{"system":"sec-edgar","filing":"0001237566-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000123756626000003/primary_doc.xml","form_type":"4"}},{"id":681334,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":21623,"kind":"person","name":"NEUPERT PETER M","position":1,"cik":"0001237566","reported_name":"NEUPERT PETER M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T00:07:56.000Z","date":"2026-08-17","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":6.32,"value":94800.0,"ownership":{"direct":true},"balance_after":255315,"source":{"system":"sec-edgar","filing":"0001237566-26-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000123756626000003/primary_doc.xml","form_type":"4"}},{"id":689226,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":24102,"kind":"person","name":"BOBULSKY SUSAN","position":1,"cik":"0001820885","reported_name":"BOBULSKY SUSAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer, MRD"}}],"security":"Common Stock","published_at":"2026-08-12T23:33:35.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":25,"value":75000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":396989,"source":{"system":"sec-edgar","filing":"0001820885-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000182088526000020/form4.xml","form_type":"4"}},{"id":698817,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":24102,"kind":"person","name":"BOBULSKY SUSAN","position":1,"cik":"0001820885","reported_name":"BOBULSKY SUSAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer, MRD"}}],"security":"Common Stock","published_at":"2026-08-03T22:26:46.000Z","date":"2026-07-30","kind":"sale","planned":true,"acquired":false,"shares":1299,"price":24,"value":31176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":399989,"source":{"system":"sec-edgar","filing":"0001820885-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000182088526000018/form4.xml","form_type":"4"}},{"id":704024,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":false,"shares":284800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option was fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":6.55,"expiration_date":"2028-02-07","underlying":"Common Stock","underlying_shares":284800},"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":704023,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"sale","planned":true,"acquired":false,"shares":213702,"price":22.12,"value":4727088.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $21.90 to $22.47, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":812058,"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":704022,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"sale","planned":true,"acquired":false,"shares":278698,"price":21.72,"value":6053320.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $20.90 to $21.89, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1025760,"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":704021,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-23T23:34:50.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":true,"shares":284800,"price":6.55,"value":1865440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."}],"balance_after":1304458,"source":{"system":"sec-edgar","filing":"0001780851-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000017/form4.xml","form_type":"4"}},{"id":705694,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":24102,"kind":"person","name":"BOBULSKY SUSAN","position":1,"cik":"0001820885","reported_name":"BOBULSKY SUSAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer, MRD"}}],"security":"Common Stock","published_at":"2026-07-20T23:19:49.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":23,"value":115000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":401288,"source":{"system":"sec-edgar","filing":"0001820885-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000182088526000016/form4.xml","form_type":"4"}},{"id":706918,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":22711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":37511,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":22711},"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":706917,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":23677,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":132246,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":23677},"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":706916,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":59374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":7.8,"expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":59374},"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":706915,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":105762,"price":22.59,"value":2389163.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.49 to $22.78, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":230713,"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":706914,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":22711,"price":8.46,"value":192135.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":336475,"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":706913,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":23677,"price":12.14,"value":287438.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":313764,"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":706912,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-17T23:23:59.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":59374,"price":7.8,"value":463117.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":290087,"source":{"system":"sec-edgar","filing":"0001780660-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000019/form4.xml","form_type":"4"}},{"id":713652,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-07T22:52:49.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":146889,"price":22.45,"value":3297658.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $22.15 to $22.75, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1019658,"source":{"system":"sec-edgar","filing":"0001780851-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000015/form4.xml","form_type":"4"}},{"id":713651,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":28994,"kind":"person","name":"ROBINS HARLAN S","position":1,"cik":"0001780851","reported_name":"ROBINS HARLAN S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-07-07T22:52:49.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":239351,"price":21.74,"value":5203490.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $21.15 to $22.145, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":1166547,"source":{"system":"sec-edgar","filing":"0001780851-26-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780851/000178085126000015/form4.xml","form_type":"4"}},{"id":715373,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":12637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":60222,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":12637},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715372,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":12600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":155923,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":12600},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715371,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":12626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":59374,"derivative":{"exercise_price":7.8,"expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":12626},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715370,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":14064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options vested with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":126584,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":14064},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715369,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":81265,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715368,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":12206,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 4, 2024, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":72859,"derivative":{"exercise_price":8.46,"expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":12206},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715367,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":168523,"derivative":{"exercise_price":12.14,"expiration_date":"2032-03-04","underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715366,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option is fully vested and exercisable."}],"balance_after":72000,"derivative":{"exercise_price":7.8,"expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715365,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":44838,"price":22.59,"value":1012890.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.49 to $22.79, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":230713,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715364,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":12637,"price":8.46,"value":106909.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":275551,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715363,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":12600,"price":12.14,"value":152964.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":262914,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715362,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":12626,"price":7.8,"value":98482.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":250314,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715361,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":42261,"price":22.5,"value":950872.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.49 to $22.54, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":237688,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715360,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":8743,"price":22.18,"value":193919.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.48 to $22.47, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4."}],"balance_after":279949,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715359,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":14064,"price":8.12,"value":114199.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":288692,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715358,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":4688,"price":3.99,"value":18705.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":274628,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715357,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":12206,"price":8.46,"value":103262.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":269940,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715356,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":3300,"price":12.14,"value":40062.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":257734,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715355,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":29767,"kind":"person","name":"LO FRANCIS","position":1,"cik":"0001780660","reported_name":"LO FRANCIS","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-07-06T23:19:35.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":7.8,"value":27300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025."}],"balance_after":254434,"source":{"system":"sec-edgar","filing":"0001780660-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780660/000178066026000017/form4.xml","form_type":"4"}},{"id":715166,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":24102,"kind":"person","name":"BOBULSKY SUSAN","position":1,"cik":"0001820885","reported_name":"BOBULSKY SUSAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer, MRD"}}],"security":"Common Stock","published_at":"2026-07-06T23:15:56.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":487,"price":22,"value":10714.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2025."}],"balance_after":406288,"source":{"system":"sec-edgar","filing":"0001820885-26-000014","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000182088526000014/form4.xml","form_type":"4"}},{"id":722736,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":51570,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options vested with respect to 1/4 of such shares on March 4, 2026, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":113457,"derivative":{"exercise_price":8.12,"expiration_date":"2035-03-04","underlying":"Common Stock","underlying_shares":51570},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}},{"id":722735,"issuer":{"id":1126,"kind":"organization","name":"Adaptive Biotechnologies Corp","symbol":"ADPT"},"owners":[{"id":34454,"kind":"person","name":"BENZENO SHARON","position":1,"cik":"0001780854","reported_name":"BENZENO SHARON","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Ofc Imm Med"}}],"security":"Stock Option (right to buy)","published_at":"2026-06-30T23:25:11.000Z","date":"2026-06-29","kind":"exercise","planned":true,"acquired":false,"shares":24944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options vested with respect to 1/4 of such shares on March 4, 2025, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested."}],"balance_after":87303,"derivative":{"exercise_price":3.99,"expiration_date":"2034-03-04","underlying":"Common Stock","underlying_shares":24944},"source":{"system":"sec-edgar","filing":"0001780854-26-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1478320/000178085426000008/form4.xml","form_type":"4"}}],"next_cursor":"2026-06-30T23:25:11.000000Z,722735"}